Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms
A Randomized Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms
1 other identifier
interventional
127
1 country
1
Brief Summary
This study will compare nasal saline irrigation with nasal saline spray for the treatment of chronic nasal and sinus symptoms. Participants will complete a questionnaire regarding their nasal and sinus symptoms and will be randomly assigned to one of the treatment groups. Each participant will be instructed on how to perform daily nasal treatment.The subjects will complete follow-up surveys at regular intervals to assess any change in their nasal symptoms after starting nasal saline treatment. Participants may take their usual medications for sinus symptoms during their participation in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Dec 2005
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 21, 2006
CompletedFirst Posted
Study publicly available on registry
April 25, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedJanuary 30, 2015
January 1, 2015
7 months
April 21, 2006
January 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in the mean score of the sinonasal outcome test-20
Change in medication usage for nasal and sinus symptoms
Study Arms (2)
Spray
ACTIVE COMPARATORsubjects were instructed in the technique of nasal lavage (irrigation group) or nasal saline spray (spray group) and were asked to do the assigned treatment twice daily for 8 weeks. They were provided with an 8-week supply of materials (Sinus Rinse irrigations from NeilMed Products Inc, and Deep Sea nasal saline spray distributed by Major Pharmaceuticals, Livonia, Michigan).
Irrigation
EXPERIMENTALsubjects were instructed in the technique of nasal lavage (irrigation group) or nasal saline spray (spray group) and were asked to do the assigned treatment twice daily for 8 weeks. They were provided with an 8-week supply of materials (Sinus Rinse irrigations from NeilMed Products Inc, and Deep Sea nasal saline spray distributed by Major Pharmaceuticals, Livonia, Michigan).
Interventions
subjects were instructed in the technique of nasal lavage (irrigation group) or nasal saline spray (spray group) and were asked to do the assigned treatment twice daily for 8 weeks. They were provided with an 8-week supply of materials (Sinus Rinse irrigations from NeilMed Products Inc, and Deep Sea nasal saline spray distributed by Major Pharmaceuticals, Livonia, Michigan).
subjects were instructed in the technique of nasal lavage (irrigation group) or nasal saline spray (spray group) and were asked to do the assigned treatment twice daily for 8 weeks. They were provided with an 8-week supply of materials (Sinus Rinse irrigations from NeilMed Products Inc, and Deep Sea nasal saline spray distributed by Major Pharmaceuticals, Livonia, Michigan).
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- Presence of any one of the following symptoms for \> 4 days/week and \> 15 days in the past 1 month:
- Nasal stuffiness
- Nasal congestion
- Nasal dryness or crusting
- Abnormal nasal discharge
- Thick nasal discharge
You may not qualify if:
- Functional endoscopic sinus surgery (FESS) in the last 3 months
- Epistaxis in the last 3 months that required treatment
- Acute illness like otitis media, laryngitis, pharyngitis, or rhinitis in the last 2 weeks
- Acute attack of asthma or bronchitis in the last 2 weeks
- Inability to speak or read English
- Current use of any of the study medications regularly for more than a week in the last 1 month
- Any history of intolerance to saline treatment (if used)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- NeilMed Pharmaceuticalscollaborator
Study Sites (1)
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Pynnonen MA, Mukerji SS, Kim HM, Adams ME, Terrell JE. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg. 2007 Nov;133(11):1115-20. doi: 10.1001/archotol.133.11.1115.
PMID: 18025315DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa A Pynnonen, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Otolaryngology
Study Record Dates
First Submitted
April 21, 2006
First Posted
April 25, 2006
Study Start
December 1, 2005
Primary Completion
July 1, 2006
Study Completion
August 1, 2006
Last Updated
January 30, 2015
Record last verified: 2015-01